From the Department of Neurology (M.L.D., P.L.P.) and Neurodevelopmental Core (E.H.), Boston Children's Hospital, Harvard Medical School, MA; Metabolic Unit, Department of Clinical Chemistry, Vrije Universiteit Amsterdam (A.P., G.S.S.), and Department of Genetic Metabolic Diseases, Emma Children's Hospital, University of Amsterdam (G.S.S.), Amsterdam Neuroscience and Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, the Netherlands; and College of Pharmacy, Department of Pharmacotherapy (J.-B.R., K.M.G.), Washington State University, Spokane.
Neurology. 2020 Nov 10;95(19):e2675-e2682. doi: 10.1212/WNL.0000000000010730. Epub 2020 Sep 4.
To determine genotype-phenotype correlation in succinic semialdehyde dehydrogenase (SSADH) deficiency.
variants were studied with phenotype correlation in the SSADH natural history study. Assignment of gene variant pathogenicity was based on in silico testing and in vitro enzyme activity after site-directed mutagenesis and expression in HEK293 cells. Phenotypic scoring used a Clinical Severity Score (CSS) designed for the natural history study.
Twenty-four patients were enrolled (10 male, 14 female, median age 8.2 years). There were 24 variants, including 7 novel pathogenic variants: 2 missense, 3 splice site, and 2 frameshift. Four previously reported variants were identified in >5% of unrelated families. There was a correlation with age and presence ( = 0.003) and severity ( = 0.002) of epilepsy and with obsessive-compulsive disorder (OCD) ( = 0.016). The median IQ score was 53 (Q25-Q75, 49-61). There was no overall correlation between the gene variants and the CSS, although a novel missense variant was associated with the mildest phenotype by CSS in the only patient with a normal IQ, whereas a previously reported variant was consistently associated with the most severe phenotype.
Seven novel pathogenic and one previously unpublished benign variants were detected. There is an age-dependent association with worsening of epilepsy and presence of OCD in SSADH deficiency. Overall, there does not appear to be a correlation between genotype and phenotypic severity in this cohort of 24 patients. We did find a suspected correlation between a novel pathogenic missense variant and high functionality, and a previously reported pathogenic missense variant and maximal severity.
确定琥珀酸半醛脱氢酶(SSADH)缺乏症的基因型-表型相关性。
在 SSADH 自然史研究中,通过表型相关性研究了变体。根据计算机测试和定点诱变后的体外酶活性以及在 HEK293 细胞中的表达,对基因变异的致病性进行了赋值。使用为自然史研究设计的临床严重程度评分(CSS)进行表型评分。
共纳入 24 例患者(男 10 例,女 14 例,中位年龄 8.2 岁)。共发现 24 种变异,包括 7 种新的致病性变异:2 种错义变异,3 种剪接位点变异和 2 种移码变异。在 >5%的无亲缘关系的家族中发现了 4 种先前报道的变异。年龄、癫痫的存在(=0.003)和严重程度(=0.002)以及强迫症(OCD)与 SSADH 缺乏症有相关性(=0.016)。中位数智商(IQ)评分为 53(25%-75%:49-61)。尽管在唯一智商正常的患者中,一种新的错义变异与 CSS 表现出的最轻者相关,但基因变异与 CSS 之间并未呈现出总体相关性。
检测到 7 种新的致病性和 1 种以前未发表的良性变体。在 SSADH 缺乏症中,癫痫恶化和 OCD 存在与年龄有关。总体而言,在这 24 例患者的队列中,基因型与表型严重程度之间似乎没有相关性。我们确实发现一种新的致病性错义变异与高功能之间存在疑似相关性,以及一种以前报道的致病性错义变异与最大严重程度之间存在相关性。